Last reviewed · How we verify
Biliary dyskinesia
Approved treatments
- Abovis
Abovis works by binding to the muscarinic acetylcholine receptor, a protein that plays a key role in regulating various bodily functions. - Cospanon
FLOPROPIONE works by inhibiting the enzyme Catechol O-methyltransferase, which plays a role in the regulation of bile flow.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Biliary dyskinesia patent landscape — cliff calendar, originator estates, attackable patents
- Biliary dyskinesia treatment landscape brief
- Biliary dyskinesia treatment updates RSS
Frequently asked questions about Biliary dyskinesia
What drugs treat Biliary dyskinesia?
Tracked treatments include Abovis, Cospanon.
What is the treatment for Biliary dyskinesia?
Standard treatment for Biliary dyskinesia includes Abovis, Cospanon. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Biliary dyskinesia patent cliff · Biliary dyskinesia CI report
- Treatment: Abovis
- Treatment: Cospanon
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing